ArticlePloS one2014

ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.

Peter Hammarsten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.